Notus Mucus (Acetylcysteine)

Acetylcysteine breaks disulfide bonds within mucopolysaccharide chains, decreasing the viscosity of mucus. By disrupting the gel structure, it transforms thick, tenacious secretions into thinner fluid that can be more readily cleared by ciliary action and coughing.

The specific dose of Notus Mucus is determined by the prescribing clinician based on the patient’s age, condition severity, renal function and route of administration. Healthcare providers select the appropriate strength and frequency in accordance with local guidelines and product labeling.

Safety data for acetylcysteine during pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Notus Mucus product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with agents such as carbocysteine or bromhexine, acetylcysteine directly cleaves disulfide bonds, offering a rapid reduction in mucus viscosity. Clinical choice depends on factors like patient tolerance, specific indication, formulation availability and local practice guidelines.

Notus Mucus should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain stability and potency throughout its shelf life.

The medication can be given orally, buccally or applied topically, depending on the formulation supplied. Oral or buccal doses are usually taken with water, while cutaneous application follows the instructions on the label, ensuring even coverage of the affected area.

Although uncommon, serious adverse reactions may include bronchospasm, severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome and hepatic dysfunction. Patients should seek immediate medical attention if they experience breathing difficulty, rash, jaundice or other alarming symptoms.

Individuals with known hypersensitivity to acetylcysteine or any excipients, patients with uncontrolled asthma prone to bronchospasm, and those with severe renal impairment without appropriate dose adjustment should avoid using Notus Mucus unless directed by a physician.